Taipei has confirmed six weapons procurement agreements with the United States valued at 208.77 billion New Taiwan dollars ($6.6 billion), including a joint production initiative for large-caliber ammunition.
The contracts were finalized with the American Institute in Taiwan following legislative approval for Letters of Offer and Acceptance during ongoing budget deliberations.
The largest portion of the deal includes procurement of M142 HIMARS worth 123.53 billion New Taiwan dollars ($3.9 billion), M109A7 Paladin systems valued at 73.89 billion New Taiwan dollars ($2.3 billion), and 5.32 billion New Taiwan dollars ($168.7 million) allocated for missile stockpile replenishment, all intended for the Republic of China Army.
Delivery timelines extend to December 2032 for HIMARS, December 2034 for Paladin systems, and March 2030 for missile resupply. Additional allocations include 5.12 billion New Taiwan dollars ($162.4 million) for anti-armor missile systems and 22.87 million New Taiwan dollars ($725,974) for integrated air defense consultancy services, both expected by 2030.
A separate investment of 910.44 million New Taiwan dollars ($28.8 million) will support joint production of large-caliber ammunition, including 105 mm shells and above. The initiative, involving Taiwan’s Armaments Bureau, is scheduled to run through February 2029 and is expected to enable locally produced munitions to enter US supply chains and potentially be exported after domestic requirements are met.
The procurement follows Washington’s approval of a record $11 billion in military sales to Taiwan in 2025, reinforcing its role as Taipei’s primary arms supplier. The move has drawn criticism from Beijing amid ongoing tensions over the South China Sea.
